Overview

Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The present study aims to investigate and to assess possible neurological and neuropsychiatric events in young children in west Africa with uncomplicated P. falciparum malaria after a 3-day treatment of Artequin Paediatric under "real life conditions."
Phase:
Phase 4
Details
Lead Sponsor:
Mepha Ltd.
Collaborator:
Centre Mère et Enfant de la Fondation Chantal Biya
Treatments:
Artemisinins
Artesunate
Mefloquine